Persistent URL of this record https://hdl.handle.net/1887/116820
In Collections
This item can be found in the following collections:
Incremental Benefit of Open-Label Certolizumab Pegol plus MTX in Rheumatoid Arthritis (RA) Patients Following Double-Blind Placebo plus IVITX Treatment Out to 2 Years
- All authors
- Combe, B.; Schwartzman, S.; Massarotti, E.; Keystone, E.; Luijtens, K.; Heijde, D. van der
- Date
- 2010-06-30
- Title of host publication
- Journal of Rheumatology
- Volume
- 37
- Issue
- 6
- Pages
- 1292 - 1292